Chargement en cours...
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
BACKGROUND: Triple-negative breast cancer has extremely high risk of relapse due to the lack of targeted therapies, intra- and inter-tumoral heterogeneity, and the inherent and acquired resistance to therapies. In this study, we evaluate the potential of prostate-specific membrane antigen (PSMA) as...
Enregistré dans:
| Publié dans: | Breast Cancer Res |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6805467/ https://ncbi.nlm.nih.gov/pubmed/31640747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1205-1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|